- Filed
- Aug 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 8, 2025 | 370.7M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 320.59M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 299.67M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 246.3M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 216.75M sh |
| Capex | Q2 2025 · Jun 30, 2025 | $85K |
| Capex | Q2 2025 · Jun 30, 2024 | $167K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$10.53M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | −$21.42M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $102.68M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $135.4M |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $367K |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $818K |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $390.85M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $50.14M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $266.55M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $197.8M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | −$3.71M |
| Stockholders Equity restated | Q2 2025 · Jun 30, 2024 | $134.75M |
| Stockholders Equity restated | Q2 2025 · Mar 31, 2024 | $143.17M |
| Stockholders Equity restated | Q2 2025 · Dec 31, 2023 | −$30M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $221.65M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $202.97M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $332.82M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $347.49M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $424.28M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $93.76M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $599.37M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $343.78M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.71 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.97 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$0.06 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$0.66 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.71 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.97 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$0.06 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$0.66 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $21.49M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $44.22M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $23.36M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $40.31M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $4.39M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $8.56M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $3.57M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $4.71M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$228.62M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$290.61M |
| Net Income restated | Q2 2025 · Jun 30, 2024 | −$14.44M |
| Net Income restated | Q2 2025 · Jun 30, 2024 | −$142.23M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$90.3M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$111.51M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$16.67M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$114.74M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $8.11M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $15.5M |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $11.06M |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $18.05M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $24.36M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $51.73M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $28.72M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $54.86M |
| Revenue | Q2 2025 · Jun 30, 2025 | $32.47M |
| Revenue | Q2 2025 · Jun 30, 2025 | $67.23M |
| Revenue | Q2 2025 · Jun 30, 2024 | $39.78M |
| Revenue | Q2 2025 · Jun 30, 2024 | $72.9M |